Intended for healthcare professionals
The mission of The BMJ is to lead the debate on health and to engage, inform, and stimulate all doctors and health care researchers in ways that enable them to make better decisions and improve outcomes for patients.
Underpinning these aims, The BMJ has a set of ethical editorial principles, an ethics advisory committee, and a commitment to transparency. We try to ensure that readers, authors, and editors know as much about the background to each other’s work as possible. We do this through policies such as open peer review, declaring competing interests, and explaining the role of the bodies that fund research.
There are many other policies and principles that help The BMJ to be an ethical publisher, and we have brought all of them together in this single transparency policy. You can reach the policies listed below simply by clicking on the links.
We will add to The BMJ’s transparency policy as often as we need to. Please contact us if you feel there is anything missing.
Please follow the links to find these policies:
Competing interests
Ethics approval of research
The BMJ's ethics committee
Open access
Copyright and permission to reuse
Trial registration and data sharing
Authorship and contributorship
Patient confidentiality
Publishing images of patients
Our peer review process
Previous peer review reports
Peer reviewing research done by BMJ editors
Evidence based publishing at The BMJ
Editorial research at The BMJ
Occupational workforce research
Previous publication
Duplicate publication and plagiarism
Corrections and retractions
Scientific misconduct
Article provenance
Role of professional medical writers
Reporting industry-sponsored trials
Competing interests of The BMJ's editorial staff
Competing interests of The BMJ's editorial advisory board
BMJ (publishing group) advertising and sponsorship policy
Articles criticising doctors and others
The BMJ aims to ensure that all articles published in The BMJ report on work that is morally acceptable, and expects authors to follow the World Medical Association's Declaration of Helsinki.
All research in The BMJ is published Open Access. Please see full details of our approach on our page about copyright, open access and permissions.
A competing interest — often called a conflict of interest — exists when professional judgment concerning a primary interest (such as patients' welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). We believe that, to make the best decision on how to deal with an article, we should know about any competing interests that authors may have, and that if we publish the article readers should know about them too.
There are differing definitions of scientific misconduct. At The BMJ, we deal with these problems on a case by case basis while following guidance produced by the major publication ethics bodies.
Our policy is based on the UK's data protection law and the English common law of confidentiality. UK authors should be aware that the General Medical Council has extensive guidance on patient consent and confidentiality and that our policy is in line with GMC advice.
The BMJ's editors treat all submitted manuscripts as confidential documents, which means they will not divulge information about a manuscript to anyone without the authors' permission. During the process of manuscript review the following people may also have access to manuscripts:
• Editors and editorial staff at The BMJ, including medical students on placement and occasional overseas visitors - usually doctors or editors from other journals;
• External reviewers, including statisticians and experts in trial methods;
• Members of the journal's editorial committees, comprising the final stage in our peer review process for original research articles;
• The only occasion when details about a manuscript might be passed to a third party without the authors’ permission is if the editor suspects serious research misconduct.
The BMJ sometimes publishes articles that criticise health professionals. Being a professional implies operating to a higher ethical standard than the general population. Thus, when balancing the interest of patients and the profession against those of an individual professional, The BMJ has an obligation to give more weight to the interests of patients and the profession than might be the case if a publication was balancing the interest of a lay individual against those of the general community.
The BMJ has guidelines on articles in which the health professionals are clearly identified and those in which they are not, and some elements are common to both.
All submissions to The BMJ must conform to the International Committee of Medical Journal Editors uniform requirements for manuscripts submitted to biomedical journals. Our requirements reflect those of the ICMJE, although we also have specific requirements for different types of article and particularly detailed ones for research articles.
The BMJ follows The International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations 2018) with regards to authorship, contributorship and group authorship.
Guidelines about informing workforces about the results of research in which they have participated before publication in mass media. Research undertaken with workforces can take place only with their full cooperation. Understandably, they expect to hear from the researchers about the results of the research and its implications for them before publication in the mass media.
The BMJ's policy on AI applies to all authors and contributors submitting content for publication in a BMJ title. It applies to all types of content, including original research, debate, opinion, journalism. It applies to all formats, including, without limitation, all text, audio, video and audio-visual material, abstracts, databases, tables, data, diagrams, photographs and other images or illustrative materials.
All BMJ journals publish content which is free from financial ties to the tobacco industry. The principle of excluding content funded by the tobacco industry applies to all content. This is to avoid our journals being used in the service of industry to downplay the harms of tobacco and related products such as vapes.
Read the full policy on BMJ Author Hub
Release of material to the media
All content in a BMJ Group journal is strictly embargoed until it posts into the public domain, so should not be disseminated, including on social media, before that date.
This is to ensure that clinicians and the public are able to access content as soon as it appears in the media.
We accept that reports may appear in the media after presentations at scientific meetings. Authors wishing to submit their work to a BMJ Group journal should not give the media any further information beyond what was included in the presentation.
Please advise if your work has been presented at a scientific meeting, has been posted on a preprint server or has been publicised in any way, including on social media, before submission.
Responsibility for advising any co-authors, funders, and employers of imminent publicity rests with the corresponding author.
If we decide not to press release a particular item, we are happy for authors (or their organisations) to issue their own press release. This can be done by requesting the external release protocol of the relevant journal’s production editor. This allows you to select a preferred online posting date/time and provides a pdf of the article for distribution to journalists.
Press releases
BMJ Group regularly publicises content of interest to journalists from our portfolio of 65+ journals. This includes original research papers, analysis articles, commentaries, editorials, letters, consensus statements, case reports and podcasts.
We do this primarily via press releases and social media engagement.
Press releases are designed to generate news coverage, and content is selected on the basis of its news potential for a general (non-medical) audience. Some journals are a richer source of newsworthy articles than others.
Press releases are sent to around 3,000 media outlets across every platform around the world. We also flag content to recipients on smaller lists, categorised by geographical region or area of interest.
We exclude lobby/consumer/charity/campaign groups to preserve editorial independence and so as not to favour any particular organisation or group.
Press release content
Press releases are based purely on the content of an article and aim to promote the journal, the science, and perform some public service. They are not intended to endorse particular policies or to boost the profile of individual organisations.
Press releases aim to provide a balanced summary of the content, written in plain English. They don’t include content that is not in the article itself or personally attributed quotes. Funder information is included in the notes for editors at the bottom of the press release.
We always provide author contact details for further information or for interview requests on the press release. If you prefer to nominate a co-author or your press office to handle media queries, please provide the relevant details.
An out of hours contact number is also helpful for the press office to enable us to respond to requests out of hours.
The corresponding author will be sent draft text to check for accuracy and clarity and provide contact details a maximum of 24-48 hours in advance.
Our embargoed press releases are posted on EurekAlert (the website of the American Association for the Advancement of Science) and once the embargo has lifted, on BMJ Group’s Media Hub.
Responding to journalists
If you agree to be a contact for journalists, please ensure you are available during the embargo period and respond promptly to any media requests: journalists work to very tight deadlines. Don’t be surprised if you aren’t contacted at all during the embargo period. Unless they have queries about the content itself, journalists may simply prefer to seek comment from alternative sources. However, if your research is particularly topical or controversial, you may receive multiple media requests.
Press embargoes
Press releases are usually embargoed until 23:30 hours (UK time) on the day of online publication.
Embargoes ensure that all parties are adequately prepared and they enable competing journalists to work to a common deadline, giving them ample time to produce balanced and well informed copy.
During the embargo period you can talk to journalists, but nothing must be published or broadcast before the embargo lifts. A broken embargo usually limits the overall media coverage rather than increases it and creates chaos for all the parties involved.
For further information please contact the media relations team: mediarelations@bmj.com